Little Green Pharma Ltd (ASX: LGP) has entered into an agreement with Frankfurt-headquartered and licenced pharmaceutical wholesaler, Ilios Santé GmbH for the supply of a non-exclusive LGP white label medicinal cannabis product into Germany.
The Agreement highlights the continued success of LGP’s extensive genetics programme which has resulted in a world-class bank of cannabis cultivars including over 20 strains in various stages of development.
Little Green Pharma Chief Executive Officer, Fleta Solomon, said the Agreement is a welcome addition to LGP’s rapidly expanding suite of high-value supply agreements from its Danish Facility into the EU, joining agreements with AMP, Demecan and Four 20 Pharma in Germany with an aggregate potential value of ~$35 million over three years.
These agreements represent the fruition of LGP’s strategy of producing large- volume bespoke strain white-label products for supply into Europe and the UK while servicing these markets with its own, LGP branded products.
The Agreement also consolidates LGP’s growing industry reputation as one of the leading global pure-play medicinal cannabis suppliers operating in Europe.
This partnership with Ilios Santé is very exciting as it not only strengthens our share of the medicinal cannabis product market in Germany but at the same time strategically partners us with The Bloomwell Group, a European leader in medical cannabis groups operating along the entire value chain. We look forward to collaborating with Ilios Santé to help service our rapidly growing number of medicinal cannabis patients in Germany,” Ms Solomon said.
About Ilios Santé & The Bloomwell Group
Ilios Santé is an EU Good Distribution Practices (GDP) licensed pharmaceutical wholesaler headquartered in Frankfurt, Germany and a wholly-owned subsidiary of leading German medical cannabis healthcare company, The Bloomwell Group.
The Bloomwell Group is a holding company for medical cannabis companies with a mission to build, acquire and invest in ESG healthcare companies along the entire value chain outside of cultivation.
As part of the Bloomwell Group, Ilios Santé is part of a fully integrated group of distinct cannabis-related brands, each fulfilling a different purpose, including Ilios Santé in the medicinal cannabis space, Algea Care, Europe’s leading telemedicine platform, and Bloomwell’s lifestyle brand, Breezy.